DK0401653T3 - Anvendelse af naftopidil til terapi af dysuri ved godartet prostata-hypertrofi - Google Patents

Anvendelse af naftopidil til terapi af dysuri ved godartet prostata-hypertrofi

Info

Publication number
DK0401653T3
DK0401653T3 DK90110207.9T DK90110207T DK0401653T3 DK 0401653 T3 DK0401653 T3 DK 0401653T3 DK 90110207 T DK90110207 T DK 90110207T DK 0401653 T3 DK0401653 T3 DK 0401653T3
Authority
DK
Denmark
Prior art keywords
dysuria
naphthopidil
therapy
benign prostatic
prostatic hypertrophy
Prior art date
Application number
DK90110207.9T
Other languages
Danish (da)
English (en)
Inventor
Gisbert Dr Med Vet Sponer
Ulrich Reicke
Michael D Nelboeck-Hochstetter
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6382247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0401653(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of DK0401653T3 publication Critical patent/DK0401653T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK90110207.9T 1989-06-07 1990-05-30 Anvendelse af naftopidil til terapi af dysuri ved godartet prostata-hypertrofi DK0401653T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918543A DE3918543A1 (de) 1989-06-07 1989-06-07 Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie

Publications (1)

Publication Number Publication Date
DK0401653T3 true DK0401653T3 (da) 1993-03-29

Family

ID=6382247

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90110207.9T DK0401653T3 (da) 1989-06-07 1990-05-30 Anvendelse af naftopidil til terapi af dysuri ved godartet prostata-hypertrofi

Country Status (19)

Country Link
US (1) US5026706A (el)
EP (1) EP0401653B1 (el)
JP (1) JPH062673B2 (el)
KR (1) KR0131452B1 (el)
AT (1) ATE84416T1 (el)
AU (1) AU625766B2 (el)
CA (1) CA2017619C (el)
DD (1) DD294864A5 (el)
DE (2) DE3918543A1 (el)
DK (1) DK0401653T3 (el)
ES (1) ES2054147T3 (el)
GR (1) GR3007328T3 (el)
HK (1) HK46996A (el)
HU (1) HU206976B (el)
IE (1) IE62937B1 (el)
IL (1) IL94601A (el)
PH (1) PH26690A (el)
PT (1) PT94268B (el)
ZA (1) ZA904338B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
EP1832598A3 (en) 1999-09-30 2008-01-02 Hollis-Eden Pharmaceuticals Inc. Therapeutic treatment of androgen receptor driven conditions
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
BR102012000187A2 (pt) * 2012-01-05 2018-04-10 Univ Rio De Janeiro Derivados n-fenilpiperazínicos antagonistas de adrenoceptores a1a, a1d e de receptores 5-ht1a no tratamento da hiperplasia prostática benigna, composições farmacêuticas contendo os mesmos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.

Also Published As

Publication number Publication date
KR0131452B1 (ko) 1998-04-17
ATE84416T1 (de) 1993-01-15
EP0401653B1 (de) 1993-01-13
HU206976B (en) 1993-03-01
JPH0324014A (ja) 1991-02-01
AU5628290A (en) 1990-12-13
DE59000748D1 (de) 1993-02-25
PT94268A (pt) 1991-02-08
PT94268B (pt) 1997-01-31
US5026706A (en) 1991-06-25
DE3918543C2 (el) 1991-06-06
ES2054147T3 (es) 1994-08-01
KR910000152A (ko) 1991-01-29
IE902014L (en) 1990-12-07
CA2017619A1 (en) 1990-12-07
EP0401653A2 (de) 1990-12-12
HUT54494A (en) 1991-03-28
PH26690A (en) 1992-09-15
DD294864A5 (de) 1991-10-17
GR3007328T3 (el) 1993-07-30
HU903515D0 (en) 1990-10-28
IE62937B1 (en) 1995-03-08
IL94601A (en) 1994-06-24
AU625766B2 (en) 1992-07-16
JPH062673B2 (ja) 1994-01-12
EP0401653A3 (de) 1991-07-17
ZA904338B (en) 1991-03-27
CA2017619C (en) 1995-06-20
IL94601A0 (en) 1991-04-15
DE3918543A1 (de) 1990-12-13
HK46996A (en) 1996-03-22

Similar Documents

Publication Publication Date Title
EA200000220A1 (ru) Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
DK0719558T3 (da) Ranolzin og beslægtede piperazin til anvendelse ved behandling af chocktilstande
ATE63906T1 (de) 3,5-disubstituierte 4,5-dihydroisoxazole als transglutaminasehemmer.
SE8302774D0 (sv) Raffinerad, detoxifierad endotoxinprodukt samt sett att framstella detsamma jemte en terapeutisk komposition som innehaller produkten
DK262585D0 (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DE69733654D1 (de) Anwendung von thermotherapie
ATE130589T1 (de) Verwendung von wässrigen kationischen kunststoffdispersionen zum imprägnieren und grundieren von saugfähigen substraten.
DK0401653T3 (da) Anvendelse af naftopidil til terapi af dysuri ved godartet prostata-hypertrofi
DE69025405D1 (de) Verbesserung beim bleichen von pulpe
DK499586D0 (da) Heterocykliske forbindelser, fremgangsmaade til fremstilling af samme samt anvendelse af disse forbindelser
DK262485A (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
ATE90568T1 (de) Verwendung von zink- oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen.
FI803461L (fi) Framstaellning och anvaendning av aemnen som reglerar tillvaexten hos vaexter
TR200101745T2 (tr) 4,5-Azolo-oksindoller
SE8500845L (sv) Forfarande for framstellning av glyoxylylspermidin och anvendningen derav for framstellning av 15-deoxispergualin-beslektade foreningar
DE3787954D1 (de) Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen.
DK422688D0 (da) Substituerede pyridylethanolaminer og fysiologisk acceptable salte og n-oxider deraf, deres fremstilling og anvendelse samt mellemprodukter og disses fremstilling
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
DE58909244D1 (de) Verwendung von 1,4-Dihydropyridin-Derivaten in der Behandlung von Alkoholsucht.
EA200200321A1 (ru) Апоптин-ассоциированный белок
NO900710L (no) Fremgangsmaate for destruering av hypokloritter i en opploesning av perklorat.
DE69711422D1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
NO863454D0 (no) Fremgangsmaate ved injeksjon av vann i underjordiske formasjoner.
ATE61585T1 (de) N-carboxyalcoyl-2-oxo-3-diaryl-5-6 triazine als heilmittel.
NO900709L (no) Fremgangsmaate for destruering av hypoklorit i en kloratopploesning.